Non-stimulant for adult ADHD moving into Phase 3 trials
Neurovance’s Phase 2b trial of the non-stimulant drug centanafadine SR has met both the primary and secondary endpoints. The research will move into Phase 3 trials in early 2017. http://www.medicalnewstoday.com/releases/311974.php...
read more